#VisualAbstract:Insulin icodec is more effective than insulin glargine for glycemic control
In this randomized controlled trial, weekly insulin icodec use resulted in better glycemic control than daily insulin glargine in patients with ...
In this randomized controlled trial, weekly insulin icodec use resulted in better glycemic control than daily insulin glargine in patients with ...
1. In this randomized controlled trial, weekly insulin icodec use resulted in better glycemic control than daily insulin glargine in ...
Click here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved. No works may be ...
1. At 26 weeks, the mean change in HbA1c was comparable between the weekly insulin icodec and daily glargine U100 ...
1. From baseline to 52 weeks, tirzepatide resulted in a greater reduction in mean HbA1c levels compared to insulin glargine. ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.